Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Nonaka

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
Radiology|March 31, 2026
Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung CancerRobert O'Shea, Carolyn Horst, Thubeena Manickavasagar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2015
Diagnostic Mutation Profiling and Validation of Non-Small-Cell Lung Cancer Small Biopsy Samples using a High Throughput PlatformAnne Marie Quinn, Nicholas Hickson, Megan Adaway, et al.
European Radiology|February 22, 2024
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([<sup>18</sup>F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancerDaniel Johnathan Hughes, Eleni Josephides, Robert O'Shea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancerRadosław Polański, Cassandra L Hodgkinson, Alberto Fusi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinomaDanit Lebanony, Hila Benjamin, Shlomit Gilad, et al.
Proteomics|June 2, 2011
Quantitative peptidomic analysis by a newly developed one-step direct transfer technology without depletion of major blood proteins: its potential utility for monitoring of pathophysiological status in pregnancy-induced hypertensionYoshihiko Araki, Daisuke Nonaka, Atsushi Tajima, et al.
Clinical Lung Cancer|February 6, 2025
A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA)Eleni C Josephides, Daniel Smith, Andrea Bille, et al.
Journal of Gastroenterology|March 3, 2018
Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP<sup>®</sup>-MS analysisKazuhiko Uchiyama, Yuji Naito, Nobuaki Yagi, et al.
European Urology Oncology|April 2, 2019
Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate CancerMarina A Parry, Shambhavi Srivastava, Adnan Ali, et al.
Cancer Immunology, Immunotherapy : CII|October 11, 2005
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patientsLorenzo Pilla, Roberto Patuzzo, Licia Rivoltini, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
Radiology|March 31, 2026
Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung CancerRobert O'Shea, Carolyn Horst, Thubeena Manickavasagar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2015
Diagnostic Mutation Profiling and Validation of Non-Small-Cell Lung Cancer Small Biopsy Samples using a High Throughput PlatformAnne Marie Quinn, Nicholas Hickson, Megan Adaway, et al.
European Radiology|February 22, 2024
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([<sup>18</sup>F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancerDaniel Johnathan Hughes, Eleni Josephides, Robert O'Shea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancerRadosław Polański, Cassandra L Hodgkinson, Alberto Fusi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinomaDanit Lebanony, Hila Benjamin, Shlomit Gilad, et al.
Proteomics|June 2, 2011
Quantitative peptidomic analysis by a newly developed one-step direct transfer technology without depletion of major blood proteins: its potential utility for monitoring of pathophysiological status in pregnancy-induced hypertensionYoshihiko Araki, Daisuke Nonaka, Atsushi Tajima, et al.
Clinical Lung Cancer|February 6, 2025
A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA)Eleni C Josephides, Daniel Smith, Andrea Bille, et al.
Journal of Gastroenterology|March 3, 2018
Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP<sup>®</sup>-MS analysisKazuhiko Uchiyama, Yuji Naito, Nobuaki Yagi, et al.
European Urology Oncology|April 2, 2019
Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate CancerMarina A Parry, Shambhavi Srivastava, Adnan Ali, et al.
Cancer Immunology, Immunotherapy : CII|October 11, 2005
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patientsLorenzo Pilla, Roberto Patuzzo, Licia Rivoltini, et al.
Pageof 20